Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-18 Sale |
2022-10-20 4:05 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
15,000 | $11.7 | $175,490 | 173,286 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-22 4:40 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
20,000 | $13.5 | $270,044 | 188,286 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-16 4:31 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
18,000 | $15.71 | $282,746 | 94,646 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-18 4:06 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
80,000 | $12.64 | $1,010,904 | 208,286 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-06 4:03 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
648 | $5.1715 | $3,351 | 20,907 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-06 4:02 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
648 | $5.1715 | $3,351 | 73,207 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 8:48 pm |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
1,445 | $10.61 | $15,334 | 78,555 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 8:25 pm |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
1,445 | $10.61 | $15,334 | 74,555 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 8:25 pm |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
1,445 | $10.61 | $15,334 | 88,555 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 8:24 pm |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
1,445 | $10.61 | $15,334 | 116,855 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 8:24 pm |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
1,445 | $10.61 | $15,334 | 74,555 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 8:24 pm |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
34,125 | $10.41 | $355,262 | 437,208 (Direct) |
View |
| 2021-07-13 Sale |
2021-07-15 4:01 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $19.01 | $570,258 | 772,858 (Direct) |
View |
| 2021-06-29 Sale |
2021-06-30 4:05 pm |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $22.35 | $223,477 | 21,514 (Indirect Direct) |
View |
| 2021-06-15 Sale |
2021-06-17 4:05 pm |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $21.97 | $659,021 | 862,858 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-15 Exercise |
2022-12-16 4:12 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
14,000 | $0.3 | 128,207 (Direct) |
View |
| 2022-12-15 Exercise |
2022-12-16 4:12 pm |
N/A 2025-02-27 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
14,000 | $0 | 128,207 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 4:05 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
15,000 | $0.39 | 173,286 (Direct) |
View |
| 2022-10-18 Exercise |
2022-10-20 4:05 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
15,000 | $0 | 173,286 (Direct) |
View |
| 2022-09-20 Exercise |
2022-09-22 4:40 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
20,000 | $0.39 | 188,286 (Direct) |
View |
| 2022-09-20 Exercise |
2022-09-22 4:40 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
20,000 | $0 | 188,286 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-16 4:31 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
18,000 | $0.39 | 94,646 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-16 4:31 pm |
N/A 2024-07-11 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
18,000 | $0 | 94,646 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 4:06 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
80,000 | $0.39 | 208,286 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 4:06 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
80,000 | $0 | 208,286 (Direct) |
View |
| 2022-08-04 Option Award |
2022-08-05 4:15 pm |
N/A 2032-08-04 |
G1 Therapeutics Inc. | GTHX | Sharpless Norman Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 5:56 pm |
N/A 2032-06-27 |
G1 Therapeutics Inc. | GTHX | Lee Jacks Director |
60,000 | $0 | 60,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:51 pm |
N/A 2032-06-23 |
G1 Therapeutics Inc. | GTHX | Secor Alicia Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:51 pm |
N/A 2032-06-23 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
40,000 | $0 | 44,389 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:51 pm |
N/A 2032-06-23 |
G1 Therapeutics Inc. | GTHX | Deese Willie A Director |
40,000 | $0 | 44,389 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:51 pm |
N/A 2032-06-23 |
G1 Therapeutics Inc. | GTHX | Flowers Cynthia Louise Director |
40,000 | $0 | 45,889 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-24 4:51 pm |
N/A 2032-06-23 |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
40,000 | $0 | 215,358 (Direct) |
View |
| 2022-02-07 Exercise |
2022-02-08 4:05 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
15,000 | $0.39 | 288,286 (Direct) |
View |
| 2022-02-07 Exercise |
2022-02-08 4:05 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
15,000 | $0 | 288,286 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
2,000 | $4.17 | 95,888 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
333 | $3.72 | 95,888 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A 2026-05-10 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
2,333 | $0 | 95,888 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
10,000 | $0.3 | 128,855 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 5:20 pm |
N/A 2025-02-27 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
10,000 | $0 | 128,855 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:48 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Hanson James S. General Counsel |
65,000 | $0 | 78,555 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:25 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
32,500 | $0 | 32,520 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:25 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | MURDOCK TERRY L Chief Operating Officer |
65,000 | $0 | 74,555 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:25 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Moses Jennifer K. CFO |
65,000 | $0 | 88,555 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:24 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Malik Rajesh Chief Medical Officer |
65,000 | $0 | 116,855 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:24 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Avagliano Mark Chief Business Officer |
65,000 | $0 | 74,555 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:24 pm |
N/A 2032-01-03 |
G1 Therapeutics Inc. | GTHX | Bailey John E. (Jack) Jr. President and CEO |
250,000 | $0 | 437,208 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-10 4:05 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
40,000 | $0.39 | 288,286 (Direct) |
View |
| 2021-11-09 Exercise |
2021-11-10 4:05 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
40,000 | $0 | 288,286 (Direct) |
View |
| 2021-08-16 Option Award |
2021-08-17 4:53 pm |
N/A 2031-08-16 |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
300,000 | $0 | 300,000 (Direct) |
View |
Ownership |
2021-08-17 4:53 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Perry Andrew Chief Commercial Officer |
0 | $0 | 20 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:01 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0.39 | 772,858 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:01 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0 | 772,858 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:05 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
2,031 | $0.3 | 21,514 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:05 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
7,969 | $0.39 | 21,514 (Direct) |
View |
| 2021-06-29 Exercise |
2021-06-30 4:05 pm |
N/A 2025-02-27 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
10,000 | $0 | 21,514 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:45 pm |
N/A 2031-06-17 |
G1 Therapeutics Inc. | GTHX | Secor Alicia Director |
52,320 | $0 | 52,320 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:25 pm |
N/A 2031-06-17 |
G1 Therapeutics Inc. | GTHX | Schwalm Cynthia Director |
24,009 | $0 | 25,509 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:06 pm |
N/A 2031-06-17 |
G1 Therapeutics Inc. | GTHX | RUDNICK SETH Director |
24,009 | $0 | 29,275 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:06 pm |
N/A 2031-06-17 |
G1 Therapeutics Inc. | GTHX | Nicholson Garry A Director |
24,009 | $0 | 24,009 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:05 pm |
N/A 2031-06-17 |
G1 Therapeutics Inc. | GTHX | MUIR GLENN P Director |
24,009 | $0 | 194,978 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:05 pm |
N/A 2031-06-17 |
G1 Therapeutics Inc. | GTHX | Deese Willie A Director |
24,009 | $0 | 24,009 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-17 4:05 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0.39 | 862,858 (Direct) |
View |
| 2021-06-15 Exercise |
2021-06-17 4:05 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
30,000 | $0 | 862,858 (Direct) |
View |
| 2021-05-25 Exercise |
2021-05-25 6:29 pm |
N/A N/A |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
20,000 | $0.39 | 348,286 (Direct) |
View |
| 2021-05-25 Exercise |
2021-05-25 6:29 pm |
N/A 2024-05-09 |
G1 Therapeutics Inc. | GTHX | Velleca Mark A. Director |
20,000 | $0 | 348,286 (Direct) |
View |